Banach M, Goch A, Misztal M, Rysz J, Zaslonka J, Goch J H, Jaszewski R
Department of Cardiology, 1st Chair of Cardiology and Cardiac Surgery, Medical University of Lodz, Lodz, Poland.
Thorac Cardiovasc Surg. 2008 Feb;56(1):20-3. doi: 10.1055/s-2007-989249.
Preoperative atrial fibrillation is one of the predictors of increased morbidity and mortality in patients undergoing surgical revascularization, and consequently, prolongs the duration of stay in the ICU and of overall hospitalization.
The study included 3000 patients subjected to primary isolated coronary artery bypass grafting from 2000 to 2004. Of the 3000 patients, 5.8 % (n = 174) had electrocardiographically documented, preoperative atrial fibrillation. To evaluate the relationship between preoperative AF and postoperative outcome, all patients were observed for about three years.
Patients with preoperative atrial fibrillation were older (P < 0.05), had a lower ejection fraction (P < 0.001), a higher incidence of heart failure (P < 0.001), hypertension (P < 0.001), and more coexistent morbidities including diabetes (P < 0.05), obturative pulmonary disease (P < 0.0001) and mild renal failure (P < 0.001). Statistical analysis showed that survival rates at 6 and 30 days, 6 and 12 months, and 3 years following surgical revascularization of patients with vs. those without preoperative atrial fibrillation were: 96.4% vs. 98.1%, and 94.5% vs. 97.3% (P = ns), 86.2% vs. 93.0% (P < 0.03), and 74.7% vs. 91.0% (P < 0.02), and 70.7% vs. 90.6% (P < 0.01). After 3 years' observation there was a survival difference of 19.9%. We showed that preoperative atrial fibrillation triple increased the risk of postoperative AF and was an independent risk factor for in-hospital death (P < 0.001).
Preoperative atrial fibrillation is a predictor of postoperative complications, including death, and of a significant reduction in patients' long-term survival. Patients with preoperative atrial fibrillation should be considered as high-risk patients with potential postoperative complications and should be well protected with antiarrhythmic and anticoagulant therapy.
术前房颤是接受外科血管重建术患者发病率和死亡率增加的预测因素之一,因此会延长重症监护病房(ICU)住院时间和总体住院时间。
该研究纳入了2000年至2004年接受初次单纯冠状动脉旁路移植术的3000例患者。在这3000例患者中,5.8%(n = 174)有术前心电图记录的房颤。为评估术前房颤与术后结局之间的关系,对所有患者进行了约三年的观察。
术前房颤患者年龄较大(P < 0.05),射血分数较低(P < 0.001),心力衰竭(P < 0.001)、高血压(P < 0.001)发病率较高,并存更多疾病,包括糖尿病(P < 0.05)、阻塞性肺病(P < 0.0001)和轻度肾衰竭(P < 0.001)。统计分析表明,有与无术前房颤患者外科血管重建术后6天和30天、6个月和12个月以及3年的生存率分别为:96.4%对98.1%,94.5%对97.3%(P = 无显著性差异),86.2%对93.0%(P < 0.03),74.7%对91.0%(P < 0.02),70.7%对90.6%(P < 0.01)。经过3年观察,生存率差异为19.9%。我们发现术前房颤使术后房颤风险增加两倍,并且是院内死亡的独立危险因素(P < 0.001)。
术前房颤是术后并发症(包括死亡)以及患者长期生存率显著降低的预测因素。术前房颤患者应被视为有潜在术后并发症的高危患者,应通过抗心律失常和抗凝治疗给予良好保护。